SCOUT-HCM demonstrated the superiority of Camzyos on the primary endpoint and multiple secondary endpointsThe overall safety results in this study were consistent with the established safety profile ...

Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...

In light of this case, there is a growing recognition of the need for regulations governing tattoo ink composition,” wrote ...

Faced with demographic collapse in her home country, the Chinese expert is conducting experiments on stem cells and human ...

The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.

Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...

The Conception supplements are the best-selling fertility support supplements on Amazon and deliver essential nutrients to ...

At 28 weeks pregnant, you’re entering your third trimester! Discover common symptoms, baby’s development, helpful tips for ...

A team of scientists from China has successfully created a miniature womb on a chip that mimics the complex environment of ...

Melanie Smith from Zion, Illinois gave birth to a health baby boy on Christmas Day, despite having no idea she was pregnant.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects total U.S. net product sales for the fourth quarter of 2025 to be ...

CASGEVY® launch acceleration continues, supporting multi-billion-dollar potential- -Broad pipeline supported by leading ...